A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906

Clinical trial NCT05296733 · COMPLETED

Trial details

NCT number: NCT05296733
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Liver Diseases Obesity

Start date: 2022-04-27
Primary completion: 2023-12-29
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.